Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-26

Clinical Trial Update: Methylphenidate-Duloxetine Combinations for Cocaine Dependence [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating methylphenidate and duloxetine combinations for cocaine use disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)
  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: University of Kentucky | Conditions: Cocaine Use Disorder | Phase 1 | Status: COMPLETED